Table 4.
Initial treatment following transformed lymphoma
Treatment | n (%) |
---|---|
Rituximab + chemotherapy | 131 (34.6) |
Rituximab monotherapy | 98 (25.9) |
Radiation | 26 (6.9) |
Chemotherapy | 25 (6.6) |
RIT | 16 (4.2) |
Investigational therapy | 16 (4.2) |
Stem cell transplantation | 6 (1.8) |
Combined modality: radiation | 5 (1.3) |
Other noninvestigational therapy | 1 (0.3) |
None | 55 (14.5) |
RIT, radioimmunotherapy.